Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 8;9(1):e82450.
doi: 10.1371/journal.pone.0082450. eCollection 2014.

Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion

Affiliations

Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion

Han Li et al. PLoS One. .

Abstract

Identifying patients with Mild Cognitive Impairment (MCI) who are likely to convert to dementia has recently attracted increasing attention in Alzheimer's disease (AD) research. An accurate prediction of conversion from MCI to AD can aid clinicians to initiate treatments at early stage and monitor their effectiveness. However, existing prediction systems based on the original biosignatures are not satisfactory. In this paper, we propose to fit the prediction models using pairwise biosignature interactions, thus capturing higher-order relationship among biosignatures. Specifically, we employ hierarchical constraints and sparsity regularization to prune the high-dimensional input features. Based on the significant biosignatures and underlying interactions identified, we build classifiers to predict the conversion probability based on the selected features. We further analyze the underlying interaction effects of different biosignatures based on the so-called stable expectation scores. We have used 293 MCI subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) database that have MRI measurements at the baseline to evaluate the effectiveness of the proposed method. Our proposed method achieves better classification performance than state-of-the-art methods. Moreover, we discover several significant interactions predictive of MCI-to-AD conversion. These results shed light on improving the prediction performance using interaction features.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Classification performances with different .
We vary formula image from 10 to 30 (formula image-axis) and report the accuracy obtained (formula image-axis) with different classification methods. The META and MRI datasets are used, and the leave-one-out performance is reported.
Figure 2
Figure 2. The proportion of selected main effect features.
Figure 3
Figure 3. The proportion of selected interaction features.
Figure 4
Figure 4. Stability selection results of the interactions features on the META (E)+MRI (M) dataset.
Figure 5
Figure 5. Stable expectation scores of the interactions features on the META (E)+MRI (M) dataset.
Figure 6
Figure 6. Stable expectation scores of related biosignatures.
We list the related biosignatures of the top 5 negative and positive stable interactions shown in Figure 5.

References

    1. Association A (2010) 2010 Alzheimer's disease facts and figures. Alzheimer's & Dementia 6: 158–194. - PubMed
    1. Petersen R (2003) Mild cognitive impairment clinical trials. Nature Reviews Drug Discovery 2: 646–653. - PubMed
    1. Ye J, Farnum M, Yang E, Verbeeck R, Lobanov V, et al. (2012) Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data. BMC neurology 12: 46. - PMC - PubMed
    1. Devanand D, Pradhaban G, Liu X, Khandji A, De Santi S, et al. (2007) Hippocampal and entorhinal atrophy in mild cognitive impairment prediction of Alzheimer disease. Neurology 68: 828–836. - PubMed
    1. Fennema-Notestine C, Hagler D, McEvoy L, Fleisher A, Wu E, et al. (2009) Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Human brain mapping 30: 3238–3253. - PMC - PubMed

Publication types